Viyash Scientific Ltd

₹240.8▼ -1.49%28 Sept

📊 Stock Analysis

Market Data

Market Cap₹10,519.96 Cr.

52W High₹297.9

Current Price₹240.8

52W Low₹178.4

Down from 52W High19.2 %

Face Value₹2

Performance

ROCE14.58 %

ROE7.5 %

EPS (TTM)₹1.51

EPS Prev Qtr₹1.2

EPS Last Year₹1.28

EBITDA Qtr₹116.61 Cr.

Book Value₹65

Financial Health

Debt/Equity0.15

Debt/Profit1.63

Total Assets₹4,628.387 Cr.

Promoter Holding61.31 %

Earning Power10.19 %

Valuation

Stock P/E39.41

Industry P/E33.81

Price to Book3.73

Price to Sales2.94

Graham Number₹94.21

Key Metrics

Face Value

₹2

About Viyash Scientific Ltd

Healthcare · Pharmaceuticals

Viyash Scientific Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹2. Market cap ₹10,519.96 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.51	₹4,41,477.63 Cr	0.87%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	86.48	₹2,53,031.38 Cr	0.31%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	77.67	₹1,85,216.32 Cr	0.78%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	27.01	₹1,20,897.46 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.28	₹1,12,201.64 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	99.31	₹1,08,698.22 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Dr Reddys Laboratories Ltd	-	31.6	₹1,02,039.12 Cr	0.65%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Mankind Pharma Ltd	-	49.29	₹1,00,752.43 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Aurobindo Pharma Ltd	-	26.56	₹97,814.24 Cr	0.24%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.64	₹94,274.49 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	36.67	₹65,922.11 Cr	0.11%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	28.65	₹61,804.34 Cr	1.03%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	110.29	₹61,113.53 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.22	₹56,860.69 Cr	1.78%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Glaxosmithkline Pharmaceuticals Ltd	-	46.73	₹49,091.33 Cr	1.97%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ipca Laboratories Ltd	-	36.13	₹48,712.48 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	83.03	₹47,949.68 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Gland Pharma Ltd	-	42.26	₹47,764.08 Cr	0.69%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ajanta Pharma Ltd	-	38.87	₹44,109.77 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	850.3	858.41	919.96	946.36
↳ QoQ Growth	-	+1.0%	+7.2%	+2.9%
Expenses	736.18	741.31	796.12	829.75
Operating Profit	114.12	117.1	123.84	116.61
OPM %	13.42%	13.64%	13.46%	12.32%
Other Income	7.46	13.98	15.92	8.31
Interest	17.51	16.75	14.52	12.51
Depreciation	59.11	58.53	60.41	61.77
EBITDA	173.23	175.63	184.25	178.38
EBITDA Margin %	20.37%	20.46%	20.03%	18.85%
Profit Before Tax	102.37	73.07	125.24	112.41
Tax %	28.79%	33.6%	47%	29.46%
Net Profit	72.9	48.52	66.38	79.29
↳ QoQ Growth	-	-33.4%	+36.8%	+19.4%
EPS	1.28	0.89	1.2	1.51

Balance Sheet

	Mar 2025	Mar 2026
Equity Capital	50.06	87.37
Reserves	654.41	2731.024
Borrowings	481.25	435.81
Other Liabilities	416.23	1374.18
Total Liabilities	1601.95	4628.387
Fixed Assets	284.35	2104.678
CWIP	15.08	68.729
Investments	0.08	0.07
Other Assets	1302.44	2454.91
Total Assets	1601.95	4628.387

Cash Flows

	Mar 2026
Cash from Operating Activity	322.913
Cash from Investing Activity	-84.118
Cash from Financing Activity	-123.334
Net Cash Flow	115.461

Shareholding Pattern

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters %	52.33%	61.41%	61.31%	61.31%
FIIs %	5.91%	3.16%	2.94%	4.5%
DIIs %	12.91%	7.36%	7.98%	3.76%
Public %	22.72%	19.24%	18.97%	20.52%
No. of Shareholders	1,44,085	1,34,194	1,27,446	1,28,367